Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
NCT01290471
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Malignant Tumors
Advanced Ovarian Cancer
Interventions
DRUG:
U3-1565
Sponsor
Daiichi Sankyo